Rehabilitation: A routine physical therapy program prescribed by a specialist physician and physiotherapist will be applied.
Study summary
This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.
Eligibility
Sex
ALL
Min age
40 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* Having regular neurology follow-up and using medicine;
* Hoehn and Yahr Scale Stage between 1-3 points;
* Mini-Mental State Assessment Score \>24 points;
Exclusion Criteria:
* Having a secondary neurological disease;
* Any surgery and/or trauma affecting the upper extremity
* Having complaints of pain before the treatment program;
* There was a change in medical treatment during the study;
* With symptoms of anxiety and depression;
* Those who use alcohol and drugs;
* Individuals with vision defects that cannot be corrected by the use of glasses and those with hearing loss
Primary outcome measure(s)
Parkinson Disease Questionnaire-8 — 7 days before the Physiotherapy session It is an 8-item form used to assess the quality of life in Parkinson's disease.
Parkinson Disease Questionnaire-8 — First day of the physiotherapy session It is an 8-item form used to assess the quality of life in Parkinson's disease.
Parkinson Disease Questionnaire-8 — 6 weeks (5 physiotherapy sessions for 6 weeks) It is an 8-item form used to assess the quality of life in Parkinson's disease.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.